102 related articles for article (PubMed ID: 12011767)
1. Immunohistochemical investigations of cathepsin D activity in the structures of cholesteatoma.
Chodynicki S; Chyczewski L; Olszewska E
Med Sci Monit; 2002 May; 8(5):BR184-6. PubMed ID: 12011767
[TBL] [Abstract][Full Text] [Related]
2. Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma.
Hansen T; Unger RE; Gaumann A; Hundorf I; Maurer J; Kirkpatrick CJ; Kriegsmann J
Mod Pathol; 2001 Dec; 14(12):1226-31. PubMed ID: 11743044
[TBL] [Abstract][Full Text] [Related]
3. Proliferation activity and apoptosis in granulation tissue and cholesteatoma in middle ear reoperations.
Durko M; Kaczmarczyk D
Folia Morphol (Warsz); 2004 Feb; 63(1):119-21. PubMed ID: 15039916
[TBL] [Abstract][Full Text] [Related]
4. Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas.
Juhász A; Sziklai I; Rákosy Z; Ecsedi S; Adány R; Balázs M
Otol Neurotol; 2009 Jun; 30(4):559-65. PubMed ID: 19395987
[TBL] [Abstract][Full Text] [Related]
5. Role of N-acetyl-beta-d-hexosaminidase in cholesteatoma tissue.
Olszewska E; Olszewski S; Borzym-Kluczyk M; Zwierz K
Acta Biochim Pol; 2007; 54(2):365-70. PubMed ID: 17502924
[TBL] [Abstract][Full Text] [Related]
6. [The expression of Ras protein in human middle ear cholesteatoma].
Xu Y; Jin K; Dong W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity and cell proliferation index in cholesteatoma.
Lee SH; Jang YH; Tae K; Park YW; Kang MJ; Kim KR; Park CW
Acta Otolaryngol; 2005 Jul; 125(7):707-12. PubMed ID: 16012031
[TBL] [Abstract][Full Text] [Related]
8. Osteoclast stimulating and differentiating factors in human cholesteatoma.
Hamzei M; Ventriglia G; Hagnia M; Antonopolous A; Bernal-Sprekelsen M; Dazert S; Hildmann H; Sudhoff H
Laryngoscope; 2003 Mar; 113(3):436-42. PubMed ID: 12616193
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
[TBL] [Abstract][Full Text] [Related]
10. Structural changes and protein expression in the mastoid bone adjacent to cholesteatoma.
Cinamon U; Kronenberg J; Benayahu D
Laryngoscope; 2000 Jul; 110(7):1198-203. PubMed ID: 10892696
[TBL] [Abstract][Full Text] [Related]
11. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
Liu J; Lin G; Huang J; Jiang Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791
[TBL] [Abstract][Full Text] [Related]
12. Some markers of proliferative activity in cholesteatoma epithelium in adults.
Olszewska E; Chodynicki S; Chyczewski L; Rogowski M
Med Sci Monit; 2006 Aug; 12(8):CR337-40. PubMed ID: 16865065
[TBL] [Abstract][Full Text] [Related]
13. Expression of RANKL and OPG in middle ear cholesteatoma tissue.
Jeong JH; Park CW; Tae K; Lee SH; Shin DH; Kim KR; Park YW
Laryngoscope; 2006 Jul; 116(7):1180-4. PubMed ID: 16826057
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of p63 and survivin in cholesteatomas.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of peroxidase proliferator-activated receptor gamma in cholesteatoma.
Hwang SJ; Kang HJ; Song JJ; Kang JS; Woo JS; Chae SW; Lee HM
Laryngoscope; 2006 Jan; 116(1):58-61. PubMed ID: 16481810
[TBL] [Abstract][Full Text] [Related]
16. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal imbalances are associated with increased proliferation and might contribute to bone destruction in cholesteatoma.
Ecsedi S; Rákosy Z; Vízkeleti L; Juhász A; Sziklai I; Adány R; Balázs M
Otolaryngol Head Neck Surg; 2008 Nov; 139(5):635-40. PubMed ID: 18984256
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of Ki-67 expression in recurrent cases of cholesteatoma].
Sanli A; Tezer I; Paksoy M; Aydin S; Hardal U; Ozdemir NB
Kulak Burun Bogaz Ihtis Derg; 2007; 17(2):65-9. PubMed ID: 17527055
[TBL] [Abstract][Full Text] [Related]
19. Expressions of caspase-14 in human middle ear cholesteatoma.
Jung MH; Lee JH; Cho JG; Jung HH; Hwang SJ; Chae SW
Laryngoscope; 2008 Jun; 118(6):1047-50. PubMed ID: 18520823
[TBL] [Abstract][Full Text] [Related]
20. Cathepsin L activity and its inhibitor in human otitis media.
Kusunoki T; Nishida S; Murata K; Kobashi K; Nakatani H; Hiwasa T; Tomura T
J Otolaryngol; 2001 Jun; 30(3):157-61. PubMed ID: 11771045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
